The review frames metal nanoparticles as antibacterial agents whose activity depends on underlying mechanisms rather than a single universal mode of action.
First-pass extracted concept
metal nanoparticles
Extracted Explainers
What the tool is doing
What problem it solves
What it does not solve
Evidence Snippets
Supporting Sources
Linked Claims
Nanomaterial-based ultrasound-enhanced contrast agents and treatment platforms are associated with high safety profile, low cost, and excellent biocompatibility.
owing to their high safety profile, low cost and excellent biocompatibility
Biosafety and clinical translation remain challenges for nanomaterial-assisted ultrasound approaches.
Despite the significant progress in this field, challenges regarding the biosafety and clinical translation of nanomaterials remain.
Nanomaterial-based ultrasound-enhanced contrast agents and treatment platforms are important tools for tumor diagnosis and treatment.
ultrasound-enhanced contrast agents and treatment platforms based on nanomaterials have become important tools for tumor diagnosis and treatment
The antibacterial activity of metal nanoparticles is described as depending on physicochemical determinants including size, shape, charge, and facets.
The review synthesizes antibacterial mechanisms of metal and metal-oxide nanoparticles in terms of physicochemical determinants, ROS generation, ion release, membrane damage, and downstream genomic or proteomic responses.